For Benefits Providers
Employers & Plan Sponsors
Productivity in the workplace improved through personalized medicine
Mental Illness is a Serious and Costly Condition in the Canadian Workplace
Mental health challenges represent a significant economic and productivity concern within Canadian organizations. Beyond employee wellbeing, these conditions directly reduce workplace output.
Productivity losses occur through multiple mechanisms: absenteeism (employee absences) and presenteeism (working while unwell, reducing work quality). Both patterns contribute meaningfully to organizational performance declines.
The Scale of the Challenge
40%
of long-term disability claims in Canada are related to mental health
70%
of total disability costs stem from mental health claims
30%
rise in mental health disability claims from 2021 to 2025
3.1M
Canadians live with a mental health-related disability
Sources: HR Reporter (2024); BBD (2024); Sun Life Group Benefits Disability Experience Study (2021–2025); Statistics Canada (2025).
The Impact of Medication
Antidepressant failure represents a significant factor in chronic illness cases. Traditional prescribing involves trial-and-error methodologies, extending recovery timelines and producing frustrating adverse effects that impair workplace functioning.
The Solution: Pharmacogenomics
Pharmacogenomic testing analyzes individual genetic profiles to identify optimal antidepressant compatibility with minimal adverse effects. This personalized approach enhances treatment outcomes, reduces side effects, and boosts productivity.
Important: Service quality varies significantly. Selecting providers offering comprehensive genetic markers specifically relevant to antidepressants ensures accurate assessments and superior treatment recommendations.
Pharmacogenetic Service
Pharmacist Assisted Medication Management
The service delivers pharmacogenetics and psychopharmacology assistance for employees and dependents at minimal cost.
Less than $1 per month
per employee
Privacy & Security
Canadian-Based Operations
Company based in Toronto with patient privacy protected under Canadian law.
Data Protection
Information not shared with third parties (insurers). Coverage decisions cannot be based on genetic testing.
Anti-Discrimination Act
Protected under Canada’s Genetic Non-Discrimination Act.
Patient Control
Results shared only with consenting individuals.
Add Pharmacogenetics to Your Benefits Plan
Contact us to learn how pharmacogenetic testing can benefit your organization.